πŸ‡ΊπŸ‡Έ FDA
Patent

US 10383940

Copper-cysteamine and methods of use

granted A61KA61K31/30A61K41/0057

Quick answer

US patent 10383940 (Copper-cysteamine and methods of use) held by The Board of Regents of the University of Texas System expires Mon Aug 15 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Aug 20 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 15 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/30, A61K41/0057, A61K51/025, A61K51/0478